Cipla takes deal route with Alvotech to enter Australian autoimmune biosimilars market: GlobalData
On March 2, 2021, Cipla Gulf and Alvotech expanded their partnership to market and distribute four biosimilars; aflibercept…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Cipla
Cipla Gulf expands partnership with Alvotech for commercialisation of biosimilars in Australia and…
Cipla has announced that it’s subsidiary, Cipla Gulf is expanding its partnership with Alvotech for the marketing and distribution…
The tale of three patriots
Chandru Chawla, a pharma veteran, reviews the book titled, 'Caring for Life - The Cipla Story', written by Tulsi Vatsal on the…
Cipla celebrates 85 years with the launch of its book ‘Caring For Life: The Cipla Story Since 1935’
A compassionate approach to medicine and healthcare that goes beyond the pursuit of profit and growth—this has been the force…
Blueprint for progress
Experts and veterans examine and explore strategies for India Pharma Inc to implement the lessons learnt from the COVID-19…
Cipla, Strides Pharma recall drugs in the US market
Cipla has recalled packets of esomeprazole magnesium for delayed-release oral suspension while Strides Pharma has recalled…
India has key role to play in equitable distribution of COVID-19 vaccines: Industry experts
Experts bat for global cooperation and coordination to tackle COVID-19 pandemic
Cipla launches rapid antigen detection test to diagnose COVID-19
The test will be marketed under the brand name CIPtest
Cipla settles patent litigation of Revlimid (lenalidomide) capsules with Celgene
Celgene has agreed to provide Cipla with a license to Celgene’s patents required to manufacture and sell certain volume-limited…
Cipla signs licensing pact with MultiG for COVID-19 rapid antibody test kit
'Covi-G' has been commercialised in 20+ countries, with sensitivity and specificity exceeding 92 per cent, informs company